Actress Christina Applegate, 54, is investigating the potential connection between her breast implants and her ongoing pain and fatigue after finding out she had been misdiagnosed with multiple sclerosis (MS) in 2021.
During the November 10 episode of MeSsy, the podcast she co-hosts alongside actor Jamie-Lynn Sigler, Applegate, who became well-known as a teenager on the popular sitcom Married With Children, shared that a recent study highlighting symptoms related to breast implants resembling those of MS was sent to her.
“I really thought to myself, ‘What if they’re leaking and poisoning me?’ over the past five years or so,” she remarked, indicating her intention to bring this concern up with her healthcare providers.
-
As Christina Applegate reveals MS misdiagnosis, doctor warns of wrong treatment risks
-
The subject of Lyme disease is littered with misinformation. Celebrities are part of the problem, experts say
In 2008, Applegate underwent a double mastectomy and subsequent breast reconstruction after her diagnosis of an early stage of breast cancer and her identification as a carrier of the BRCA1 gene mutation, which increases the likelihood of breast and other cancers. She mentioned on her podcast that she is “way overdue” for replacing her implants.
Additionally, she has reported experiencing increasing pain and mobility challenges in her right shoulder, stating it can take her a minimum of 10 minutes to sit up and get out of bed. She described these symptoms as overwhelming since “there are so many different things that could be involved.”
This inquiry follows her doctors confirming in October that she does not have MS. At that time, Applegate expressed that the revelation left her back at “Square 1,” as her physical difficulties persist and she is being tested for other potential conditions, including rheumatoid arthritis, lupus, and Lyme disease.
Although the underlying cause of Applegate’s symptoms is still unclear, breast implants have been associated with certain health issues in some instances, though this condition is not thoroughly understood.
What is known about breast implant illness

Breast implant illness, or BII, refers to symptoms experienced by some individuals with implants, such as fatigue, cognitive changes, joint pain, and muscle pain. This image depicts a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)
Breast implant illness, commonly abbreviated as BII, encompasses a range of symptoms reported by certain individuals with implants.
As of December 31, 2025, Health Canada documented 663 reports of symptoms or illnesses linked to breast implants — roughly one report for every 1,025 implants sold in Canada.
Fatigue was noted as the most commonly reported symptom, followed by mood changes, gastrointestinal issues, and cognitive alterations. These are reports rather than confirmed diagnoses: Health Canada indicates that the existing information cannot verify whether implants were the cause of the symptoms, as they might stem from other factors.
The U.S. Food and Drug Administration (FDA) states that BII is not recognized as an official medical diagnosis and lacks a specific test. Reports of symptoms like fatigue and joint issues do not determine their frequency or establish whether implants are the cause.
Julie Elliott, a patient advocate, licensed practical nurse (LPN), and Canadian representative for the Breast Implant Safety Alliance (BISA), who claims to have been diagnosed with an autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome) due to her breast implants, informed CBC News that certain symptoms reported by individuals with implants can overlap with those of MS.
-
National breast implant registry much needed but long overdue, patients and doctors say
-
Alberta women with breast implant illness urge doctors to warn others of risk
“Chronic fatigue, memory changes, concentration difficulties, numbness, tingling, nerve pain, muscle weakness, hair loss, and more — these symptoms are quite similar to those of MS,” Elliott noted.
However, she cautioned against hastily concluding that Applegate’s implants are the source of her issues. “I’m not asserting that Christina Applegate’s breast implants are to blame for her symptoms,” she said, explaining that it would be “premature and irresponsible” to make that assumption.
“Similar symptoms do not automatically imply the same diagnosis,” Elliott stated. “Nothing should be disregarded or dismissed without comprehensive medical examination.”

Christina Applegate, left, attends the 29th Screen Actors Guild Awards in Century City, California, on February 26, 2023. (Valerie Macon/AFP/Getty Images)
Dr. Stephen Nicolaidis, a plastic surgeon based in Montreal who has consulted with over 1,500 patients regarding implant removal, also underscored the importance of exploring other potential causes.
He described BII as a “diagnosis of exclusion,” where patients need to undergo thorough evaluations, and if no alternative cause is found, the possibility that the implants could be contributing to the issues should be considered.
Nicolaidis mentioned that common symptoms he encounters include fatigue, hair loss, skin rashes, breathing challenges, joint and muscle pain, sleep disturbances, and brain fog. Some of these may coincide with symptoms related to autoimmune disorders.
Referring to the symptoms Applegate has publicly discussed, he stated, “The symptoms she has experienced can certainly be linked to her breast implants.” Nevertheless, the origins of BII remain unclear, and he noted that researchers have yet to provide conclusive answers regarding how implants may influence symptoms.
According to Nicolaidis, there is no specific test available for diagnosing BII. Imaging can reveal silicone leakage outside an implant, but such a finding is not necessary for someone to report symptoms. He also emphasized that BII differs from implant-associated lymphoma, which is a cancer associated with certain textured implants.
Rupture, removal, and next steps
A rupture or leak presents a different issue than BII. The FDA identifies rupture and deflation as potential complications of implants and recommends that patients consult with a healthcare provider about any new or unusual breast changes.
In a similar vein, Health Canada advises individuals with implants to routinely monitor for unusual breast changes and discuss any signs or symptoms with their doctor. Decisions regarding whether to keep, replace, or remove implants should involve a clinician, taking into account individual symptoms, potential causes, and associated surgical risks.
The agency does not endorse routine implant removal as a preventive measure due to the risks involved in surgery, and it recommends that individuals experiencing symptoms consult with a healthcare professional.
-
Struggling with pain for years, N.S. woman heads to Montreal for breast implant removal
-
Video
The costly, complex, and dangerous world of removing medical devices | The Implant Files
Nicolaidis encouraged individuals with symptoms to seek a comprehensive medical assessment. If no other causes are identified, they can discuss whether the implants might be playing a role and consider their options with their healthcare providers.
He stopped performing breast implant placements in 2021, believing that the risks often outweigh the benefits, and has shifted his focus primarily to implant removal. He emphasizes that removal does not guarantee a cure, as some patients he has treated for MS reported only minimal improvement, and those with diagnosed autoimmune conditions may still need medical treatment following explant surgery.
Elliott believes it is important to take symptoms related to implants seriously, while recognizing that their origins are not completely understood. She urged patients to seek reliable, evidence-based information and to monitor their health changes closely.
“The absence of all the answers does not mean that women’s experiences should be dismissed,” she remarked.
